The relatively new drugs the first being approved by the Food and Drug Administration (FDA) in 2005 also signal a significant shift in how hospitals and health systems treat chronic conditions such as type 2 diabetes and heart disease
Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression
Weight loss from GLP-1 therapy may reduce your thyroid hormone requirements, potentially necessitating a lower levothyroxine dose
Guida C, Stephen SD, Watson M, Dempster N, Larraufie P, Marjot T, et al
GLP-1s are a class of drugs that have been around for the past 20 years
This may be why CLA supplements have been associated with several negative side effects, while CLA from food has not